B5387e98-figure-01 (B5387e98 Figure 01)
Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 64980-645
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 64980-645). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
B5387e98-figure-02 (B5387e98 Figure 02)
B5387e98-figure-03 (B5387e98 Figure 03)
B5387e98-figure-04 (B5387e98 Figure 04)
This data table shows the adverse events occurring in greater than 1% of more than one treatment group and illustrates the combination treatment group with the highest percentage for each event. The body system categories include Body as a Whole, Digestive, Musculo-skeletal, Respiratory, and Urogenital, with specific conditions and percentages of patients affected by each adverse event such as Pain, Diarrhea, Cramps Leg, Bronchitis, Lung Disease, and Infection urinary tract. This information can be helpful for healthcare professionals to evaluate and monitor potential side effects of treatment options.*
Carton-30ct-label (Carton 30ct Label)
This text appears to be a description of a medication containing Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg in an inhalation solution form. The medication is for oral inhalation only and is used to treat conditions such as asthma or chronic obstructive pulmonary disease (COPD). It provides details on the active ingredients and dosage.*
Carton-60ct-label (Carton 60ct Label)
This is a prescription medication with the National Drug Code (NDC) 64980-245.00. It contains Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg for oral inhalation only. The medication is intended for respiratory use.*
Figure-1 (Figure 1)
Figure-2 (Figure 2)
Figure-3 (Figure 3)
Figure-4 (Figure 4)
Vial Label (Vial Label)
This is a detailed label of a medication containing Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg per 3 mL vial. The medication is for oral inhalation only and should be used under the direction of a physician. It is stored between 20°C to 25°C and should be protected from light. Each vial should be used within one week after removing it from the foil pouch. The inactive ingredients include Sodium chloride, hydrochloric acid, and water for injection. The product is distributed by Rising Pharma Holdings, Inc. with customer service contact information provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
